BREAKING
BioAge Labs 2025 Financial Results Analysis 38 minutes ago Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap 59 minutes ago Hour Loop, Inc. (HOUR) Reports FY2025 Results 1 hour ago Heidmar Maritime Holdings Corp. (HMR) Misses Q4 EPS Estimates 2 hours ago Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 2 hours ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 3 hours ago Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates 3 hours ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 3 hours ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 3 hours ago BioAge Labs 2025 Financial Results Analysis 38 minutes ago Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap 59 minutes ago Hour Loop, Inc. (HOUR) Reports FY2025 Results 1 hour ago Heidmar Maritime Holdings Corp. (HMR) Misses Q4 EPS Estimates 2 hours ago Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 2 hours ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 2 hours ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 3 hours ago Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates 3 hours ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 3 hours ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 3 hours ago
ADVERTISEMENT
Market News

Brown & Brown Posts Q4 Revenue Jump Amid Organic Decline

Brown & Brown, Inc. (NYSE: BRO) shares traded around 79.18 on Tuesday, near the lower end of its 52-week range of 76.17 to 125.68. The insurance brokerage firm announced its fourth-quarter and full-year 2025 financial results, reporting a significant increase in total revenue for the quarter. Quarterly Performance For the fourth quarter ended December 31, […]

January 27, 2026 1 min read

Brown & Brown, Inc. (NYSE: BRO) shares traded around 79.18 on Tuesday, near the lower end of its 52-week range of 76.17 to 125.68. The insurance brokerage firm announced its fourth-quarter and full-year 2025 financial results, reporting a significant increase in total revenue for the quarter. Quarterly Performance For the fourth quarter ended December 31, […]

Brown & Brown, Inc. (NYSE: BRO) shares traded around 79.18 on Tuesday, near the lower end of its 52-week range of 76.17 to 125.68. The insurance brokerage firm announced its fourth-quarter and full-year 2025 financial results, reporting a significant increase in total revenue for the quarter.

Quarterly Performance

For the fourth quarter ended December 31, 2025, Brown & Brown reported total revenues of 1.6 billion, marking a 35.7% increase compared to 1.18 billion in the same period of 2024. Despite the strong top-line growth driven by acquisitions, the company’s organic revenue experienced a decrease of 2.8%. Diluted net income per share stood at 0.59, down 19.2% from 0.73 in Q4 2024. Adjusted diluted net income per share, a non-GAAP measure, increased 8.1% to 0.93 from 0.86 year-over-year. The adjusted EBITDAC margin remained flat at 32.9%.

Full-Year Review

For the full fiscal year 2025, Brown & Brown’s total revenues climbed 22.8% to 5.9 billion, up from 4.8 billion in 2024. Full-year organic revenue grew by 2.8%. Adjusted diluted net income per share for the full year increased 10.9% to 4.26 from 3.84 in the prior year.

Analyst Activity

There were no specific analyst upgrades, downgrades, or price target changes reported today in connection with the earnings release. Recent broader market sentiment has noted some analyst downgrades and concerns regarding softer property and casualty pricing.

ADVERTISEMENT